Harneet Singh Rishi (@rishihs) header
Harneet Singh Rishi (@rishihs) profile picture

Scientist-Engineer-Data Nerd | #Data at KariusDx, NovomeBio | PhD @UCBerkeley #ArkinLab | #F1 #Lakers fan

South San Francisco, CA
Joined August 2014
Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)Photo by Harneet Singh Rishi (@rishihs)
Ease-of-use of spreadsheets + database-inspired structure + reproducible analysis and reporting = 😎^ 🙌 Excited to see the release of Tabulous from an amazingly talented team I've had the pleasure of working with in the past!
2
328
Christmas came early this year with @_hex_tech releasing one of the most feature-packed (and funniest) launches I’ve ever seen. Kudos to the team for continuing to push the envelope for analytics/DS tooling. Improved AI workflows + multi-tab app support + 🏎️ upgrades = 😎^🔥
Tomorrow's Hex 3.0 launch event features Barry (CEO), Gerald (head of aerospace materials division), Olivia (AI engineer), Izzy (missing in employee db?) and more great folks from our team. 🔴 Live on Thursday at 10am PT, tune in: hex.tech/hex-three-point-oh
1
8
1,893
Harneet Singh Rishi retweeted
I’m really excited to share our new pre-print “Genome-wide Characterization of Diverse Bacteriophages Enabled by RNA-Binding CRISPRi”, with co-first author Muntathar Al-Shimary @doudna_lab and the newly-minted @bradyfcress lab! biorxiv.org/content/10.1101/… 🧵🧵 1/
13
70
6
188
49,244
Harneet Singh Rishi retweeted
Super thrilled to announce that we secured BRaVE initiative funding to establish "Phage Foundry" with a dream team!! 🥳 Aim is to develop a foundational platform that integrates many aspects of phage research and rapidly design countermeasures for AMR pathogens.
How can we be more ready in the future for a major biosecurity event? @ENERGY is providing $112.4 M for 10 research projects to support the Biopreparedness Research Virtual Environment (BRaVE) initiative, which will leverage our unique capabilities: energy.gov/science/articles/…
17
20
4
143
30,496
Harneet Singh Rishi retweeted
Biological data is growing exponentially. It’s difficult to reconcile and work with all of it. That’s why we’re building a Cloud for Biology. blog.latch.bio/the-cloud-for…
4
54
11
178
67,498
When you think about a feature suggestion for @_hex_tech, start writing the email, and then see you just got an email about how they’re already doing it 🤯🤩😎
Today we are launching a private beta of 🔮 Hex Magic 🪄 AI-powered tools to help humans do amazing things with data. Check it out and sign up for the waitlist here: hex.tech/magic/
1
1
8
930
Harneet Singh Rishi retweeted
#News: Excited to share we’ve secured $43.5 million in our Series B financing to advance our ongoing Phase 2a clinical trial in #hyperoxaluria and pipeline of #GEMMs candidates for #IBD. Learn more: novomebio.com #celltherapy #livingmedicines
Harneet Singh Rishi retweeted
💸 We raised a Series B to hire more amazing people, ship even more great features, and help data teams go from analyzing data to ✨creating knowledge✨. Read more about where we're going and why on the blog: hex.tech/blog/series-b
5
13
28
202
Harneet Singh Rishi retweeted
Introducing the Knowledge Library, a new set of workflows in Hex that empower teams to create knowledge from their work. hex.tech/blog/knowledge-libr…
1
1
2
35
Harneet Singh Rishi retweeted
High-impact data work isn’t about churning out analysis; it’s about creating ⚡️knowledge⚡️ This is why I’m so excited about the new Knowledge Library features in @_hex_tech! hex.tech/blog/knowledge-libr… A 🧵:
8
10
7
76
Congrats @ben_a_adler!
Our Salmonella phage-host interaction paper (and my first-first author) is finally out! Please check it our if you're interested in Salmonella, phage, or high-throughput genetic screens! Lots of time, effort, and sequencing went into this one 😅
1
3
An exciting milestone for the @novomebio team as we report promising results from our Phase 1 demonstrating robust and controllable engraftment of our #GEMMs platform in humans - the first time for a therapeutically engineered microbe in the human GI tract! #synbio #celltherapy
#News: Excited to share positive Phase 1 results of our orally-administered #GEMM, NOV-001, which produced high levels of engraftment of our engineered strain in the GI tract. Learn more here: bit.ly/3kKqo1g #celltherapy #IBD #livingmedicines
Exciting news for Novome today as we announce our partnership with @genentech for inflammatory bowel disease #IBD! Read more about it 👇
#News: Exciting day here as we enter a collaboration with @Genentech to leverage our #GEMMs platform to develop targets against inflammatory bowel disease. Learn more here: bit.ly/3H9gvn3 #celltherapy #IBD #livingmedicines
1
7
An exciting milestone for @novomebio as we dose our first subject ever in our Ph1 trial on the path to a treatment for enteric #hyperoxaluria!
#News: We’ve dosed our first subject in the Phase 1 clinical trial evaluating our once-daily oral #GEMM candidate for the potential treatment of enteric #hyperoxaluria. bit.ly/3qAYiqM #GEMMs #celltherapy #gutmicrobiome #livingmedicines
1
4
Harneet Singh Rishi retweeted
1/ We’re excited to announce the completion of our $100M Series B financing to further develop our ”CRISPR by Design” platform and pipeline of #CRISPR-based in vivo genetic medicines that treat the underlying cause of disease. bwnews.pr/3w8uBzE
3
9
9
39
Congrats Sean and team! Looking forward to reading it in depth!
It's a rare and special thing to see your work reach a satisfying conclusion. @AzadehAshley, @AlexeyKazakov8, @vivek_mutalik, @AdamArkinLab, we did it! Our study on tailocins appears in the ISME Journal as of this week. doi.org/10.1038/s41396-021-0…
3
Harneet Singh Rishi retweeted
BREAKING NEWS: The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”
674
21,911
8,389
43,592